Godavari Drugs

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE362C01012
NSEID:
BSEID: 530317
View on BSE

INR

88.10

-1.27 (-1.42%)

BSENSE

Feb 11

BSE+NSE Vol: 1.07 k

Access older stock analysis version

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Phaarmasia

Sunil Healthcare

Biofil Chemicals

Godavari Drugs

Vivo Bio Tech

Samrat Pharma

Amwill Health

Shelter Pharma

Asston Pharmaceu

Onyx Biotec

Accretion Pha.

Why is Godavari Drugs Ltd ?

Weak Long Term Fundamental Strength with a -0.27% CAGR growth in Net Sales over the last 5 years

Low ability to service debt as the company has a high Debt to EBITDA ratio of 3.27 times

Flat results in Dec 25

NET SALES(Q) Lowest at Rs 22.18 cr
EPS(Q) Lowest at Rs 1.01

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -12.99% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Godavari Drugs for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Godavari Drugs

-12.99%

-0.23

57.48%

Sensex

10.41%

0.90

11.52%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-0.27%

EBIT Growth (5y)

3.90%

EBIT to Interest (avg)

2.39

Debt to EBITDA (avg)

3.62

Net Debt to Equity (avg)

1.37

Sales to Capital Employed (avg)

2.09

Tax Ratio

22.59%

Dividend Payout Ratio

Pledged Shares

0.22%

Institutional Holding

0.50%

ROCE (avg)

13.39%

ROE (avg)

13.97%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.53

EV to EBIT

15.60

EV to EBITDA

11.89

EV to Capital Employed

1.22

EV to Sales

1.19

PEG Ratio

Dividend Yield

ROCE (Latest)

9.13%

ROE (Latest)

8.54%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Bullish

Bearish

Dow Theory

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company

NO KEY POSITIVE TRIGGERS

-4What is not working for the Company

NET SALES(Q)

Lowest at Rs 22.18 cr

EPS(Q)

Lowest at Rs 1.01

Loading Valuation Snapshot...

Here's what is not working for Godavari Drugs

Net Sales - Quarterly

At Rs 22.18 cr has Fallen at -15.9% (vs previous 4Q average)

over average Net Sales of the previous four quarters of Rs 26.38 Cr

MOJO Watch

Near term sales trend is very negative

Net Sales (Rs Cr)

Net Sales - Quarterly

Lowest at Rs 22.18 cr

in the last five quarters

MOJO Watch

Near term sales trend is negative

Net Sales (Rs Cr)

Earnings per Share (EPS) - Quarterly

Lowest at Rs 1.01

in the last five quarters

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (Rs)